SCHEMBL166376

SCHEMBL166376

CCOC(=O)c1csc(=S)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.50
ALDH1A1 P00352 8/20 0.44
MAPT P10636 7/20 0.44
RAB9A P51151 4/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
NPC1 O15118 2/20 0.44
PPARG P37231 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
HPGD P15428 4/20 0.42
GAA P10253 4/20 0.42
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 3/20 0.42
RXFP1 Q9HBX9 2/20 0.42
MAPK10 P53779 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9141793 0.81 HRH3 (0.47) ALDH1A1MAPTRAB9AKMT2AMEN1
SCHEMBL12767467 0.73 SMN1; SMN2 (0.49) MC4RALDH1A1KMT2AMEN1HPGD
SCHEMBL14896791 0.72
SCHEMBL1160497 0.71 LMNA (0.55) ALDH1A1MAPTRAB9AKMT2AMEN1
SCHEMBL2931775 0.70 KMT2A (0.53) MC4RALDH1A1MAPTRAB9AKMT2A
SCHEMBL8781331 0.70 HCRTR1 (0.59) MC4RALDH1A1MAPTRAB9AKMT2A
SCHEMBL1244037 0.68 HRH4 (0.52) ALDH1A1MAPTRAB9AKMT2AMEN1
SCHEMBL21295056 0.68 ALDH1A1 (0.44) ALDH1A1MAPTRAB9AKMT2AMEN1
SCHEMBL7551807 0.68 CYP2C19 (0.56) ALDH1A1MAPTRAB9AKMT2AMEN1
SCHEMBL1244645 0.67 RAB9A (0.43) ALDH1A1MAPTRAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424860-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE MSD K.K. (JP) 2012-03-07 EP disclosed
US-20120028970-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE MSD K.K. (JP) 2012-02-02 US disclosed
WO-2010126163-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028970-A1 HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE AR, NR5A1, ARL1 MC4R 313/4885ALDH1A1 219/4885MAPT 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.